Clinical Trials Logo
  1. Home
  2. Malignancies
  3. NCT01404728

Longitudinal Evaluation Study of Vaginal Stenosis With and Without Pelvic Radiation Therapy

Malignancies Clinical Trial

Official title:
Prospective Longitudinal Evaluation of Vaginal Stenosis and Sexual Function in Women With Pelvic Malignancies Treated With and Without Pelvic Radiation Therapy

Clinical Trial Summary

This study evaluates the effects of treatment with a vaginal dilator to reduce vaginal stenosis in women receiving pelvic radiation therapy for pelvic malignancies.

Clinical Trial Description

Vaginal stenosis can occur as a result of treatment for pelvic malignancies. Women receiving pelvic radiation therapy using a vaginal dilator 5-7 times per week will have less vaginal stenosis than women using a vaginal dilator fewer times or not at all. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01404728
Study type Observational
Source University of Colorado, Denver
Contact
Status Completed
Phase N/A
Start date January 8, 2013
Completion date March 1, 2017
View Details
See also
  Status Clinical Trial Phase
Completed NCT03384511 - The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies. Phase 4
Completed NCT03236857 - A Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory Malignancies Phase 1
Active, not recruiting NCT03005782 - Study of REGN3767 (Anti-LAG-3) With or Without REGN2810 (Anti-PD1) in Advanced Cancers Phase 1
Not yet recruiting NCT05602103 - Acute Cardiovascular Adverse Events Occuring in Children Treated by Anticancer Drugs for Malignancies
Terminated NCT00329329 - Study of Satraplatin With Capecitabine to Treat Advanced Solid Malignancies Phase 1
Completed NCT00316511 - Study of L-NDDP (Aroplatin) in Patients With Advanced Solid Malignancies or B-Cell Lymphoma Phase 1
Withdrawn NCT05253105 - A Clinical Study of TAB006 in Patients With Previously Treated, Advanced Malignancies Phase 1
Completed NCT02521389 - Assessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Various Formulations and Doses of PWT-143 Phase 1
Completed NCT01407380 - Study of PWT33597 Mesylate in Subjects With Advanced Malignancies Phase 1
Active, not recruiting NCT03678883 - 9-ING-41 in Patients With Advanced Cancers Phase 2
Not yet recruiting NCT05929495 - Phase 2, Open-label, Single-arm Study on the Use of Metformin as Adjunctive Therapy in High-grade Glioma Phase 2
Completed NCT02257476 - Extended Infusion Carfilzomib on a Weekly Schedule in Patients With Advanced Solid Tumors Phase 1
Completed NCT00320827 - Study of CS-1008 in Patients With Advanced Solid Malignancies and Lymphomas (Without Leukemic Component) Phase 1